Clinical implications of combination therapy with quizartinib and craniospinal irradiation for refractory acute myeloid leukemia positive for FMS‐like tyrosine kinase 3‐internal tandem duplication with central nervous system involvement

FMS‐like tyrosine kinase 3‐internal tandem duplication (FLT3‐ITD) mutation‐positive acute myeloid leukemia (AML) has a poor prognosis. We report the first case of successful bridge therapy of novel FLT3 inhibitor, quizartinib, to umbilical cord blood stem cell transplantation for FLT3‐ITD‐positive A...

Descripción completa

Detalles Bibliográficos
Autores principales: Suga, Makiko, Fukushima, Kentaro, Ueda, Tomoaki, Arai, Yasuyuki, Nakagawa, Shunsaku, Minami, Yosuke, Toda, Jun, Hino, Akihisa, Fujita, Jiro, Yokota, Takafumi, Hosen, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815089/
https://www.ncbi.nlm.nih.gov/pubmed/35140970
http://dx.doi.org/10.1002/ccr3.5384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815089/
https://www.ncbi.nlm.nih.gov/pubmed/35140970
http://dx.doi.org/10.1002/ccr3.5384

Ejemplares similares